Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.
Read Full NewsDrug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.
Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.
1.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
2.
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record
3.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
4.
Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A
5.
What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?
1.
Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer
2.
Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances
3.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
4.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
5.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge